Vitamin D Deficiency Treatment

Introduction to Vitamin D Deficiency

A vitamin D level of 15 ng/mL represents deficiency and requires supplementation with ergocalciferol 50,000 IU weekly for 8-12 weeks, followed by maintenance therapy of 800-1,000 IU daily, as recommended by the American Journal of Kidney Diseases 1, 2

Cardiovascular risk is substantially elevated in patients with vitamin D levels ≤15 ng/mL, with a 2.4-fold increased risk of myocardial infarction compared to those with levels ≥30 ng/mL, according to Autoimmunity Reviews 3, 4, 5
There is a two-fold increased risk of cardiovascular events in hypertensive patients with vitamin D levels <15 ng/mL, as reported by Autoimmunity Reviews 3, 4, 6, 7
Vitamin D deficiency is associated with an increased risk of secondary hyperparathyroidism, reduced bone mineral density, and higher fracture rates, as noted by the American Journal of Kidney Diseases 1, 2

The K/DOQI guidelines recommend ergocalciferol 50,000 IU weekly for 8-12 weeks for severe vitamin D deficiency (levels <15 ng/mL), as stated in the American Journal of Kidney Diseases 1, 2
Ergocalciferol is safer than cholecalciferol for high-dose therapy, though both are acceptable, according to the American Journal of Kidney Diseases 2

Measure serum calcium and phosphorus every 3 months during treatment, as recommended by the American Journal of Kidney Diseases and Praxis Medical Insights 1, 8
Discontinue all vitamin D therapy if serum calcium exceeds 10.2 mg/dL (2.54 mmol/L) or if serum phosphorus exceeds 4.6 mg/dL (1.49 mmol/L) and persists despite phosphate binders, as advised by the American Journal of Kidney Diseases and Praxis Medical Insights 1, 8

Levels <15 ng/mL represent severe insufficiency with documented adverse outcomes, including excess cardiovascular morbidity and mortality, as reported by Autoimmunity Reviews and the American Journal of Kidney Diseases 3, 4, 5, 1
The Framingham Offspring study demonstrated a two-fold increase in cardiovascular events at this level, as noted by Autoimmunity Reviews 3, 4, 5
Severe deficiency at this level poses major risk for secondary hyperparathyroidism with radiographic bone abnormalities, according to the American Journal of Kidney Diseases 2

For patients with obesity or malabsorption syndromes, higher doses of vitamin D may be required (up to 6,000 IU daily maintenance), as recommended by Metabolism: Clinical and Experimental 9
In severe malabsorption, doses of 50,000 IU 1-3 times weekly may be needed long-term, as stated by Metabolism: Clinical and Experimental 9
For patients with chronic kidney disease (CKD Stages 3-4), the same ergocalciferol loading protocol applies, with close monitoring of calcium and phosphorus, as advised by the American Journal of Kidney Diseases 1, 2